Prolonged Transcutaneous Cardiopulmonary Support for Postcardiotomy Cardiogenic Shock
- 1 May 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Asaio Journal
- Vol. 53 (3) , e1-e3
- https://doi.org/10.1097/mat.0b013e31805b8265
Abstract
Percutaneous cardiopulmonary support can be set up quickly at the bedside and provides reliable temporary mechanical circulatory support for cardiogenic shock patients. This report includes the case of a woman, age 56 years, with postoperative cardiogenic shock due to right heart failure, secondary to severe pulmonary hypertension, after mitral and tricuspid valve replacement. This was accomplished by the use of femoro-femoral Levitronix Centrimag centrifugal pump with membrane oxygenator. Adequate cardiac function returned, and the patient could be successively weaned after 37 days of support. Nitric oxide (NO) and Epoprostenol inhalation were used to enhance weaning from cardiopulmonary support. The patient recovered with ambulatory status and acceptable cardiac performance. The patient died of septicemia on postoperative day 72. In conclusion, this case report describes the safety and reliability of the Levitronix Centrimag centrifugal pump as percutaneous cardiopulmonary support for cardiogenic shock.Keywords
This publication has 5 references indexed in Scilit:
- Five-Year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shockThe Annals of Thoracic Surgery, 2004
- Mechanical Support for Postcardiotomy Cardiogenic ShockSeminars in Thoracic and Cardiovascular Surgery, 2000
- Seven Years of Experience with the Centrifugal Pump in Patients with Cardiogenic ShockThe Thoracic and Cardiovascular Surgeon, 1995
- Bio-Medicus ventricular assist device for salvage of cardiac surgical patientsThe Annals of Thoracic Surgery, 1991
- Bio-Medicus ventricular assistanceThe Annals of Thoracic Surgery, 1991